Gabapentin Under Scrutiny: 2025 Data Challenged Safety Profile
(MedPage Today) — In January 2025, we reported that some adverse events associated with gabapentin (Neurontin) may have been overestimated. Since then, new risks related to gabapentin emerged and prescribing continued to rise. Here’s what we learned…
Share this Post
More Posts
In Our Dog-Eat-Dog Medical Culture, Physicians Lose
(MedPage Today) — For years, physicians have voiced the same frustrations: declining reimbursement, increasing administrative burden, private equity infiltration, insurance company control, expanding scope creep, artificial intelligence (AI) anxiety…
Lucy’s hunter revealed: Giant crocodile terrorized early human ancestors
A newly identified crocodile species nicknamed “Lucy’s hunter” prowled Ethiopia’s rivers when Lucy’s species walked the Earth more than 3
FDA’s E-Cigarette Authorization: Fruity Vapes Not Better Than Tobacco Ones
(MedPage Today) — Fruit-flavored e-cigarettes recently authorized by the FDA were not significantly better at helping smokers quit than tobacco-flavored e-cigarettes, according to a new memo that’s likely to stir new questions about the agency…
